Rucci Carolyn M.'s Form 4 filing
Akebia Therapeutics, Inc. (AKBA) · filed Feb 4, 2026
- Accession no.
- 0002107264-26-000006
- Filed
- Feb 4, 2026
- Trade date
- Feb 2, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $97.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rucci Carolyn M.CIK 0002107264 | Officer (SVP, Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Common Stock | SSaleDisposed | −16,846 | $1.39 | −$23,415.94 | 641,304 | Direct | |
| Feb 2, 2026 | Common Stock | SSaleDisposed | −25,382 | $1.39 | −$35,280.98 | 615,922 | Direct | |
| Feb 2, 2026 | Common Stock | SSaleDisposed | −27,544 | $1.39 | −$38,286.16 | 588,378 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.